BRCA2, but not BRCA1, mutations account for familial ovarian cancer in Iceland: a population-based study
β Scribed by Thorunn Rafnar; Kristrun R. Benediktsdottir; Bjarki J. Eldon; Thorgeir Gestsson; Hafsteinn Saemundsson; Karl Olafsson; Anna Salvarsdottir; Eirikur Steingrimsson; Steinunn Thorlacius
- Book ID
- 116428363
- Publisher
- Elsevier Science
- Year
- 2004
- Tongue
- English
- Weight
- 255 KB
- Volume
- 40
- Category
- Article
- ISSN
- 0959-8049
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Previous mutational analysis for BRCA gene mutations in sporadic ovarian cancer occurring in Chinese patients in Hong Kong identified six germline BRCA1 mutations and one germline BRCA2 mutation, six of which were novel (Khoo et al., 2000). Knowledge of BRCA gene mutations in the Chinese population
Ovarian cancer is a clinically important cancer in Turkey. The contribution of BRCA1 and BRCA2 to ovarian cancer in Turkish patients has not previously been described. In this study we investigated the presence of BRCA1 and BRCA2 mutations in 102 consecutively ascertained, hospital-based, ovarian ca
## Abstract Our aim was to estimate the prevalence of mutations in the __BRCA1__ and __BRCA2__ genes among unselected incident cases of breast cancer in young women. We identified 158 incident breast cancer cases diagnosed before age 46 years in predefined geographic areas in Girona and Tarragona,